Talking About SJIA

With a disease as challenging as systemic juvenile idiopathic arthritis (SJIA), it's essential to keep the lines of communication open. Explaining to others what your child is going through can go a long way in ensuring that he or she is taken care of appropriately. Equally as important is talking to your child about the disease. Below are tips to keep in mind when speaking to various audiences.

Speaking with:

Speaking with your child

While it may be challenging to discuss health situations with your child, it is important to talk with your child about SJIA. Below are 5 tips on how to communicate with your child about SJIA.

Set a positive tone:
How you handle and discuss delicate information will help set the tone for how your child feels and talks about SJIA

Be up-front
You may want to protect your child from difficult situations, but withholding information may actually make him or her feel there is something to be embarrassed about or feared

Keep communication open
Talking and listening openly helps ensure that if your child starts feeling worse or gets new symptoms, you can consult your child's doctor as soon as possible

Be supportive
Children may feel ashamed of "being different" from their friends. Having a supportive family can make children feel more confident and empowered about facing the disease

Consider counseling
Talking to someone outside of the family, like a counselor or psychologist, can provide additional insights while helping your child work through his or her feelings about the disease


This information does not take the place of talking to your child's healthcare provider about either your child's medical condition or your child's treatment with ACTEMRA. Talk with your child's healthcare provider if you have any questions about your child's treatment with ACTEMRA.

What is ACTEMRA?

ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat patients with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older.

IMPORTANT SIDE EFFECT INFORMATION

Some people have serious infections while taking ACTEMRA, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.

Other serious side effects of ACTEMRA include tears (perforation) of the stomach and intestines, changes in blood test results, (including low neutrophil count, low platelet count, increase in certain liver function tests, and increase in blood cholesterol levels), hepatitis B infection becoming an active infection again, and nervous system problems.

ACTEMRA affects the immune system and may increase your risk of certain cancers.

Serious allergic reactions, including death, can happen with ACTEMRA. These reactions may happen with any infusion of ACTEMRA, even if they did not occur with an earlier infusion. Patients must tell their doctor if they have had a previous reaction to ACTEMRA. Patients should not take ACTEMRA if they are allergic to it or any of its ingredients.

Common side effects with ACTEMRA in patients with SJIA include upper respiratory tract infections (common cold, sinus infections), headache, and diarrhea.

Patients must tell their healthcare provider if they plan to become pregnant or are pregnant. It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while taking ACTEMRA must contact the registry at 1-877-311-8972 and talk to their healthcare provider.

Patients must call their healthcare provider for medical advice about any side effects. Patients or caregivers may report side effects to the FDA at 1-800-FDA-1088. Patients or caregivers may also report side effects to Genentech at 1-888-835-2555.

For additional important safety information, including Boxed Warning and Medication Guide, please visit ACTEMRA.com or call (800) ACTEMRA (800-228-3672).

The resource above is provided in Adobe® Reader® format (PDF). To view or print, you must have Adobe Reader (version 3.0 or higher) installed on your computer. Download the free Adobe Reader here.


© 2012 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.